Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
20.01
-0.22 (-1.09%)
At close: Nov 17, 2026
Liaoning Chengda Biotechnology Employees
Liaoning Chengda Biotechnology had 1,585 employees as of June 30, 2026. The number of employees decreased by 196 or 11.01% since the number was reported on December 31, 2025. That makes Liaoning Chengda Biotechnology the 11,760th largest employer in the world and 2,642nd in China.
Employees
1,585
Change
-196
Growth
-11.01%
Revenue / Employee
843.94K CNY
Profits / Employee
40.99K CNY
Market Cap
8.22B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1,585 | -196 | -11.01% |
| Dec 31, 2025 | 1,781 | -26 | -1.44% |
| Dec 31, 2024 | 1,807 | 75 | 4.33% |
| Dec 31, 2023 | 1,732 | 69 | 4.15% |
| Dec 31, 2022 | 1,663 | 134 | 8.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Mabwell (Shanghai) Bioscience | 1,356 |
| Chongqing Genrix Biopharmaceutical | 1,133 |
| Hualan Biological Vaccine | 708 |
| Novoprotein Scientific | 696 |